FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/100711 [Registered on: 09/01/2026] Trial Registered Prospectively
Last Modified On: 08/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   The Effect of Shatapushpa Churna in Children to improve ability to focus and concentration. 
Scientific Title of Study   A Single Arm Clinical Trial to Study the Effect of Shatapushpa Churna in Improving the Attention Span in Children of 6 to 13 Years of Age. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Gautami Kashinath Nimase 
Designation  Post Graduate Student 
Affiliation  SMBT Ayurved College and Hospital 
Address  Department of Kaumarbhritya SMBT Ayurved College and Hospital Nandi Hills Dhamangaon Ghoti Igatpuri Nashik 422403

Nashik
MAHARASHTRA
422403
India 
Phone  9049532304  
Fax    
Email  gautaminimase@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Jitesh Thakur 
Designation  Associate Professor 
Affiliation  SMBT Ayurved College and Hospital 
Address  Department of Kaumarbhritya SMBT Ayurved College and Hospital Nandi Hills Dhamangaon Ghoti Igatpuri Nashik 422403

Nashik
MAHARASHTRA
422403
India 
Phone  8329041794  
Fax    
Email  thakurjiteshyadav@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Gautami Kashinath Nimase 
Designation  Post Graduate Student 
Affiliation  SMBT Ayurved College and Hospital 
Address  Department of Kaumarbhritya SMBT Ayurved College and Hospital Nandi Hills Dhamangaon Ghoti Igatpuri Nashik 422403

Nashik
MAHARASHTRA
422403
India 
Phone  9049532304  
Fax    
Email  gautaminimase@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Dr Gautami Kashinath Nimase 
Address  Department of Kaumarbhritya SMBT Ayurved College and Hospital Nandi Hills Dhamangaon Ghoti Igatpuri Nashik 422403 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Gautami Kashinath Nimase  SMBT Ayurved College and Hospital  OPD No. 17 Department of Kaumarbhritya SMBT Ayurved College and Hospital Nandi Hills Dhamangaon Ghoti Igatpuri Nashik 422403
Nashik
MAHARASHTRA 
9049532304

gautaminimase@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SMBT Ayurved College and Hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Healthy Children of age group 6 to 13 years  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Shatapushpa Beeja (Anethum Sowa), Reference: Kaiyadeva Nighantu (Pathyapathyavibodhaka), Route: Oral, Dosage Form: Churna/ Powder, Dose: 1(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: - Madhu (Honey)), Additional Information: - Age-wise dose: 1) 6–7 years: 2.0 g 2) 8–10 years: 2.5 g 3) 11–13 years: 3.0 g
 
Inclusion Criteria  
Age From  6.00 Year(s)
Age To  13.00 Year(s)
Gender  Both 
Details  1.Children of age group 6 to 13 years.

2.Selection of Children is irrespective of their gender religion and socioeconomic status.

3.Parents who will give written consent for treatment.
 
 
ExclusionCriteria 
Details  1.Mental retardation

2.Learning disability

3.Attention deficit hyperactivity disorder

4.Autism spectrum disorder

5.Gross developmental delay

6.Visual and auditory impairment

7.Chronic illness which hampers cognition in children

8.Severely malnourished children
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Improvement in the Attention Span assessed with the help of PGI Memory Assessment Scale and Visual Cancellation Task.  1.Total Duration of Treatment :- 30 Days

2.Assessment On Baseline and at Day 30.
 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="66"
Sample Size from India="66" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   TITLE: A Single Arm Clinical Trial to Study the Effect of Shatapushpa Churna in Improving the Attention Span in Children of 6 to 13 Years of Age.

INTRODUCTION: Attention span is a key part of a child’s mental  and cognitive development. In the present day academic environment, even healthy school-going children often struggle to concentrate for long periods. This affects their ability to learn, perform well in class, and manage their emotions effectively.
                            In the past few years, many scientific theories have tried to explain how attention works, but there is no clear, universally accepted way to improve attention in normal children. Most available treatments are designed for children with conditions like ADHD and may not be suitable for healthy children.
                            In Kashyapa Samhita, Shatapushpa (Anethum Sowa), has been mentioned for its role in enhancing Medha and Smriti. Shatapushpa (Anethum sowa) is a traditional Ayurvedic herb known for enhancing intellect (Medhya) and improving digestion (Agnideepana). A few studies say that it helps to improve IQ in children. Still, there is a lack of research on its specific effect on attention span in normal, healthy school children. 
  To fill this gap, the current research has been planned to find out the effect of Shatapushpa Churna can improve attention span in children using standard psychological tests (PGI-Children memory scale and Visual Cancellation Task). This will help to confirm its use in improving attention span.
Shatapushpa Beeja (Anethum Sowa) will be purchased from GMC certified pharmacy. Drug will be administered in Churna form for 30 days. All SOP of Churna Vidhi will be strictly followed during and after treatment. Assessment will be done on Day 0 and Day 30. Interim follow up at Day 15.
SAMPLE SIZE: The sample size for the study will be 60 participants. Considering a 10% dropout rate, the total sample size will be 66 participants.

NULL HYPOTHESIS: (HO) Shatapushpa (Anethum Sowa) Churna does not improve the Attention Span in children of 6 to 13 years of age.

ALTERNATE HYPOTHESIS: (H1) Shatapushpa (Anethum Sowa) Churna improves the Attention Span in children of 6 to 13 years of age.




 
Close